发明名称 Methods of determining altered NDPK functions and the diagnosis of cystic fibrosis
摘要 A peptide of relative molecular mass less than 6500 comprising at least ten consecutive amino acid residues surrounding the phenylalanine (508), or at least ten consecutive residues including a portion of the region between residues (508 and 551), in the polypeptide sequence of human cystic fibrosis transmembrane regulator (CFTR), or a variant or precursor thereof. A peptide as defined above having between 12 and 50 amino acid residues. Methods of treating cystic fibrosis are also disclosed. A method of classifying a disease state associated with epithelial cell dysfunction in a patient is disclosed. The method includes obtaining a suitable epithelial cell sample from the patient and determining for one or more of the following whether the measured parameter is altered compared to a control epithelial cell, the measured parameters being: (i) nucleoside diphosphate kinase (NDPK) function, (ii) phosphorylation of annexin, (iii) phosphorylation of other membrane proteins, and (iv) ATPase activity.
申请公布号 US2002065225(A1) 申请公布日期 2002.05.30
申请号 US20010944030 申请日期 2001.08.31
申请人 MUIMO RICHMOND;MEHTA ANIL 发明人 MUIMO RICHMOND;MEHTA ANIL
分类号 A61K38/00;C07K14/47;C07K16/28;C12Q1/48;G01N33/50;(IPC1-7):G01N33/574;C07K7/08;A61K38/10 主分类号 A61K38/00
代理机构 代理人
主权项
地址